SE9802794D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9802794D0
SE9802794D0 SE9802794A SE9802794A SE9802794D0 SE 9802794 D0 SE9802794 D0 SE 9802794D0 SE 9802794 A SE9802794 A SE 9802794A SE 9802794 A SE9802794 A SE 9802794A SE 9802794 D0 SE9802794 D0 SE 9802794D0
Authority
SE
Sweden
Prior art keywords
new compounds
prevention
formula
treatment
acceptable salts
Prior art date
Application number
SE9802794A
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9802794A priority Critical patent/SE9802794D0/sv
Publication of SE9802794D0 publication Critical patent/SE9802794D0/sv
Priority to CA002339286A priority patent/CA2339286A1/en
Priority to DK99944966T priority patent/DK1105391T3/da
Priority to SI9930698T priority patent/SI1105391T1/xx
Priority to EP03028150A priority patent/EP1411056A3/en
Priority to PCT/SE1999/001402 priority patent/WO2000011000A2/en
Priority to CN99812176A priority patent/CN1329613A/zh
Priority to EP99944966A priority patent/EP1105391B1/en
Priority to IL14116699A priority patent/IL141166A0/xx
Priority to PT99944966T priority patent/PT1105391E/pt
Priority to KR1020017002152A priority patent/KR20010072798A/ko
Priority to JP2000566273A priority patent/JP2002523415A/ja
Priority to BR9913103-0A priority patent/BR9913103A/pt
Priority to US09/402,919 priority patent/US6579884B1/en
Priority to AU57679/99A priority patent/AU5767999A/en
Priority to AT99944966T priority patent/ATE280768T1/de
Priority to ES99944966T priority patent/ES2229763T3/es
Priority to DE69921483T priority patent/DE69921483T2/de
Priority to ARP990104163A priority patent/AR020226A1/es
Priority to ZA200100913A priority patent/ZA200100913B/en
Priority to NO20010860A priority patent/NO20010860L/no
Priority to US10/429,639 priority patent/US6790960B2/en
Priority to US10/882,097 priority patent/US20050154007A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
SE9802794A 1998-08-21 1998-08-21 New compounds SE9802794D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds
DE69921483T DE69921483T2 (de) 1998-08-21 1999-08-18 Imidazo[1,2-a]pyridin-Verbindungen, die die Magensäuresekretion inhibieren, sie enthaltende pharmazeutische Zusammensetzungen und Verfahren für ihre Herstellung
KR1020017002152A KR20010072798A (ko) 1998-08-21 1999-08-18 신규 화합물
BR9913103-0A BR9913103A (pt) 1998-08-21 1999-08-18 Composto, processo para a preparação do mesmo, formulação farmacêutica, uso do composto, processos para inibir a secreção do ácido gástrico, para o tratamento de doenças inflamatórias gastrointestinal, e para o tratamento ou profilaxia de condições que envolvem a infeção por helicobacter pylori da mucosa gástrica humana, e, formulações farmacêuticas para o uso na inibição da secreção de ácido gástrico, para o uso no tratamento de doenças inflamatórias gastrointestinais, e para o uso no tratamento ou profilaxia de condições que envolvem a infecção por helicobacter pylori da mucosa gástrica humana
SI9930698T SI1105391T1 (en) 1998-08-21 1999-08-18 Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation
EP03028150A EP1411056A3 (en) 1998-08-21 1999-08-18 Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for their preparation
PCT/SE1999/001402 WO2000011000A2 (en) 1998-08-21 1999-08-18 New compounds
CN99812176A CN1329613A (zh) 1998-08-21 1999-08-18 新的化合物
EP99944966A EP1105391B1 (en) 1998-08-21 1999-08-18 Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation
IL14116699A IL141166A0 (en) 1998-08-21 1999-08-18 New compounds
PT99944966T PT1105391E (pt) 1998-08-21 1999-08-18 Compostos de imidazo [1,2-a] piridinas que inibem a secrecao acida gastrica, composicoes farmaceuticas destes e processos para a sua preparacao
CA002339286A CA2339286A1 (en) 1998-08-21 1999-08-18 New compounds
JP2000566273A JP2002523415A (ja) 1998-08-21 1999-08-18 新規な化合物
DK99944966T DK1105391T3 (da) 1998-08-21 1999-08-18 Imidazo[1,2-a]pyridin-forbindelser som inhiberer mavesyreudskillelse, farmaceutiske præparater deraf og fremgangsmåder til deres fremstilling
US09/402,919 US6579884B1 (en) 1998-08-21 1999-08-18 Compounds
AU57679/99A AU5767999A (en) 1998-08-21 1999-08-18 New compounds
AT99944966T ATE280768T1 (de) 1998-08-21 1999-08-18 Imidazo(1,2-a)pyridin-verbindungen, die die magensäuresekretion inhibieren, sie enthaltende pharmazeutische zusammensetzungen und verfahren für ihre herstellung
ES99944966T ES2229763T3 (es) 1998-08-21 1999-08-18 Compuestos de imidazo(1,2-a)piridina que inhiben la secrecion de acido gastrico, composiciones farmaceuticas de los mismos, y procesos para su preparacion.
ARP990104163A AR020226A1 (es) 1998-08-21 1999-08-19 Compuestos para la inhibicion de la secrecion de acido gastrico, procesos para su preparacion, formulaciones farmaceuticas y uso de dichos compuestos parapreparar medicamentos
ZA200100913A ZA200100913B (en) 1998-08-21 2001-02-01 New compounds.
NO20010860A NO20010860L (no) 1998-08-21 2001-02-20 Nye forbindelser
US10/429,639 US6790960B2 (en) 1998-08-21 2003-05-05 Compounds
US10/882,097 US20050154007A1 (en) 1998-08-21 2004-06-30 New compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds

Publications (1)

Publication Number Publication Date
SE9802794D0 true SE9802794D0 (sv) 1998-08-21

Family

ID=20412307

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds

Country Status (20)

Country Link
US (3) US6579884B1 (sv)
EP (2) EP1411056A3 (sv)
JP (1) JP2002523415A (sv)
KR (1) KR20010072798A (sv)
CN (1) CN1329613A (sv)
AR (1) AR020226A1 (sv)
AT (1) ATE280768T1 (sv)
AU (1) AU5767999A (sv)
BR (1) BR9913103A (sv)
CA (1) CA2339286A1 (sv)
DE (1) DE69921483T2 (sv)
DK (1) DK1105391T3 (sv)
ES (1) ES2229763T3 (sv)
IL (1) IL141166A0 (sv)
NO (1) NO20010860L (sv)
PT (1) PT1105391E (sv)
SE (1) SE9802794D0 (sv)
SI (1) SI1105391T1 (sv)
WO (1) WO2000011000A2 (sv)
ZA (1) ZA200100913B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
NZ538595A (en) * 2002-09-19 2006-04-28 Schering Corp Pyrazolopyridines as cyclin dependent kinase (CDK) inhibitors useful in treating diseases such as cancer, leukemia, fibrosarcoma and glioma
TWI351405B (en) * 2002-09-19 2011-11-01 Schering Corp Novel imidazopyridines as cyclin dependent kinase
DK1606261T3 (da) 2003-03-10 2010-01-18 Nycomed Gmbh Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8536492B2 (en) * 2003-10-27 2013-09-17 Applied Materials, Inc. Processing multilayer semiconductors with multiple heat sources
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
US20080033006A1 (en) * 2004-01-26 2008-02-07 Altana Pharma Ag 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors
KR20070053231A (ko) * 2004-07-28 2007-05-23 다케다 야쿠힌 고교 가부시키가이샤 피롤로[2,3-ｃ]피리딘 화합물, 그 제조 방법 및 용도
DK1861074T3 (da) * 2005-03-16 2013-07-29 Takeda Gmbh Smagsmaskeret doseringsform indeholdende roflumilast
EP2099798A1 (en) * 2006-12-01 2009-09-16 Galapagos N.V. Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
EP2573080A1 (en) * 2007-09-27 2013-03-27 The United States of America, as Represented by the Secretary, Department of Health and Human Services Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
BRPI1013288A2 (pt) 2009-07-09 2016-03-29 Raqualia Pharma Inc uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto
CN111606846A (zh) * 2020-05-12 2020-09-01 广州理文科技有限公司 一种n`-三氟甲磺酰基n杂芳香胺类化合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU6646094A (en) 1993-04-22 1994-11-08 Byk Gulden New pyridinium salts and their use for controlling helicobacter bacteria
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
WO1996003402A1 (de) * 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogenimidazopyridine
WO1996003404A1 (de) * 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylimidazopyridine
NZ290818A (en) * 1994-07-28 1998-10-28 Byk Gulden Lomberg Chem Fab Benzyl-imidazopyridines
MX9700624A (es) 1994-07-28 1997-12-31 Byk Gulden Lomberg Chem Fab Azolidinonas de imidazopiridina.
DE19602853A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue Halogenimidazopyridine
EP0882048B1 (de) 1996-01-26 2005-05-04 ALTANA Pharma AG 3-alkylimidazopyridine
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802793D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
US6579884B1 (en) 2003-06-17
EP1105391B1 (en) 2004-10-27
ATE280768T1 (de) 2004-11-15
CA2339286A1 (en) 2000-03-02
EP1411056A2 (en) 2004-04-21
ES2229763T3 (es) 2005-04-16
ZA200100913B (en) 2002-05-02
KR20010072798A (ko) 2001-07-31
AU5767999A (en) 2000-03-14
AR020226A1 (es) 2002-05-02
EP1105391A2 (en) 2001-06-13
EP1411056A3 (en) 2004-04-28
DE69921483T2 (de) 2006-02-02
WO2000011000A3 (en) 2000-06-15
DK1105391T3 (da) 2005-01-24
NO20010860L (no) 2001-04-23
US20050154007A1 (en) 2005-07-14
CN1329613A (zh) 2002-01-02
WO2000011000A2 (en) 2000-03-02
PT1105391E (pt) 2005-01-31
BR9913103A (pt) 2001-05-08
JP2002523415A (ja) 2002-07-30
SI1105391T1 (en) 2005-02-28
DE69921483D1 (de) 2004-12-02
IL141166A0 (en) 2002-02-10
NO20010860D0 (no) 2001-02-20
US20030220364A1 (en) 2003-11-27
US6790960B2 (en) 2004-09-14

Similar Documents

Publication Publication Date Title
SE9704404D0 (sv) New compounds
SE9801526D0 (sv) New compounds
SE9802794D0 (sv) New compounds
SE9802793D0 (sv) New compounds
SE9700661D0 (sv) New compounds
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
SE9602286D0 (sv) New compounds
SE9401197D0 (sv) Active compounds
SE0102808D0 (sv) New compounds
NO984950D0 (no) Forbindelser med veksthormonfrigj°rende egenskaper
FI955896A0 (sv) Nya aktiva föreningar
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
AR044855A1 (es) Compuesto de imidazopiridina
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
AR044854A1 (es) Compuesto de imidazopiridina